Caribou Biosciences is a leading biotechnology company in genome engineering. We develop technology-based solutions for cellular engineering and analysis based on the CRISPR-Cas9 technology platform. Cas9, when paired with a guide RNA, cuts double-stranded DNA allowing for specific changes to DNA. These site-specific DNA modifications can be utilized to carry out sophisticated gene knock-outs or knock-ins.
Caribou's technologies mark a revolutionary development that allows scientists to engineer nearly any part of any genome with extreme flexibility. Forbes Magazine has called Cas9 the protein that "could change biotech forever" and the New York Times has noted that "the pace of new discoveries and applications is dizzying." Caribou's tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology.
|HQ||Berkeley, CA, US||Map|
|Employees (est.) (Apr 2021)||64||(+4%)|
Caribou Biosciences total Funding
Caribou Biosciences latest funding size
Time since last funding
|a month ago|
Caribou Biosciences investors
|Maverick Capital, Heritage Group, Novartis, Farallon Capital Management, Invus, Jenny Rooke, Mission Bay Capital, Anterra Capital, Tekla Capital Management, 5 Prime Ventures, F-Prime Capital Partners, Pontifax AgTech, LifeSci Venture Partners, Janus Henderson Investors, Point72, Maverick Ventures, AbbVie Ventures, Ridgeback Capital Investments, Avidity Partners, Monashee Investment Management, Adage Capital Partners, PFM Health Sciences, Avego Bioscience Capital, The Leukemia & Lymphoma Society Therapy Acceleration Program, Heritage Medical Systems, Pontifax Global Food, Agriculture Technology Fund|
Caribou Biosciences has 4.3k Twitter Followers. The number of followers has increased 1.8% month over month and increased 5.3% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Caribou Biosciences founded?
Caribou Biosciences was founded in 2011.
Who are Caribou Biosciences key executives?
Caribou Biosciences's key executives are Rachel Haurwitz, Barbara McClung and Santhosh Palani.
How many employees does Caribou Biosciences have?
Caribou Biosciences has 64 employees.
Who are Caribou Biosciences competitors?
Competitors of Caribou Biosciences include Biocytogen, Sana Biotechnology and Definigen.
Where is Caribou Biosciences headquarters?
Caribou Biosciences headquarters is located at 2929 Seventh Street, Berkeley.
Where are Caribou Biosciences offices?
Caribou Biosciences has an office in Berkeley.
How many offices does Caribou Biosciences have?
Caribou Biosciences has 1 office.
Receive alerts for 300+ data fields across thousands of companies